Nevada forces drugmakers to reveal insulin pricing, profits

The Associated Press

CARSON CITY, Nev. — Nevada Gov. Brian Sandoval signed into law Thursday the nation’s strictest requirements for pharmaceutical companies to reveal how they set certain prescription drug prices.

The bipartisan legislation focuses on insulin — one of many life-sustaining prescription treatments sold in the U.S. at prices that have skyrocketed over the last decade.

The law requires drugmakers to annually disclose the list prices they set, profits they make and discounts they give market middlemen on insulin.

They must also give state officials written explanations of any insulin price hikes that surpass the previous year’s inflation rate, or are higher than twice the inflation rate of the previous two years.

Market experts have said transparency on its own will not lower patient costs.

But a leading bill sponsor, Democratic Sen. Yvanna Cancela of Las Vegas, argued that detailed pricing data can start conversations about seeking even stricter regulations and at least could equip patients with information they could use to sue manufacturers for price gouging.

Nevada’s focus on insulin struck a chord nationally. Supporters from across the country flooded the governor’s mailbox and email inboxes with letters urging him to sign the bill while patient groups rallied proponents using social media.

Culinary Union 226, whose leaders shaped and lobbied for the legislation this year, organized some of its 57,000 members to hang fliers and knock on doors to promote the bill in the Las Vegas area.

“I’ve had several near-death experiences because I couldn’t afford my insulin,” Las Vegas resident Rita Neanover said in a Thursday statement from the union. “I’m so relieved Nevada is finally doing something about this issue.”

The bulk of the legislation takes effect in October, but the first disclosures will be due on April 1, 2018.

America’s three insulin manufacturers will face fines of $5,000 daily if they fail to provide the data without explaining why.

It was unclear whether opponents intend to comply with the law or challenge the rules in court.

However, the leading organization of market middlemen who negotiate prices between drugmakers and insurers, called pharmacy benefit managers, suggested that the law’s “costly fiduciary mandate” resembles legislation that federal courts have previously rejected based on violations of federal benefits laws.

They also believe that the law could raise their costs, said Pharmaceutical Care Management Association spokesman Greg Lopes.

It will “grant the kind of transparency that the Federal Trade Commission and economists say will raise costs by giving drug companies inside information that would empower them to collude with their competitors,” Lopes said in a statement.

The law requires drugmakers to provide detailed information about their prices. Some companies already voluntarily make some of that information public, but Nevada’s law will mandate that they do so in greater detail.

Some drugmakers have voluntarily released recent data on price increases but most companies currently keep specific data confidential.

The regulations are rivaled only by a recent state law in Vermont asking drugmakers to justify certain price increases of 15 percent or more.

In addition to the insulin-specific requirements, Nevada’s law will outlaw “gag rules” that bar pharmacists from suggesting alternate or less-expensive prescription options.

All drugmakers will also have to register sales representatives who market prescription drugs in Nevada.

Nonprofit organizations operating in Nevada that advocate on behalf of patients or fund medical research, which could range from local diabetes networks to the American Red Cross, will be required to disclose donations they receive from pharmaceutical companies, insurance companies or benefit managers.

The proposal transitioned from a first-of-its-kind price control to a measure focused on pricing transparency during Nevada’s four-month legislative session that adjourned last week.

Sandoval vetoed a version of the bill that included a requirement for drug manufacturers to give public notice 90 days before raising insulin prices.

Sandoval said in a veto message that that could create a perverse incentive for some companies to manipulate insulin supplies. Bill sponsors removed that provision.””

Nevada Gov. Brian Sandoval speaks before signing Senate Bill 539 during a signing ceremony Thursday, June 15, 2017, in North Las Vegas, Nev. The bill aims to force America’s three insulin manufacturers to annually turn over the prices they set and profits they make on insulin. 

AP Photo/John Locher

SportsPlus

McNeese Sports

Cowboys drop opener to Jackrabbits

Local News

Sulphur water quality conversations to be held this week

Crime

11/4: Calcasieu Parish Sheriff announces arrest list

Local News

UPDATE: Helicopter crash victim was a student pilot

McNeese Sports

Cowgirls roll in front of loud crowd

Local News

PHOTO GALLERY: Calcasieu fifth-graders fill Legacy Center

Crime

Allen correctional officer arrested for inappropriate contact with inmate

Local News

UPDATE: Family of three killed in copter crash identified

Local News

Supreme Court will weigh in on new mostly Black Louisiana congressional district after election

Local News

Tropical Depression 18 forms in Caribbean, expected to enter Gulf of Mexico

McNeese Sports

Davey back to form in Cowboy win

life

‘Kids need adults who care,’ says Calcasieu Kiwanis Club’s McGinley

Business

Names in the News: People shaping the future of Lake Area business

McNeese Sports

Cowboys enjoy Happy Homecoming

Local News

Iran’s supreme leader threatens Israel, U.S. with ‘crushing response’ to Israeli attack

Local News

It’s a fight to the finish in races that will determine control of Congress

Local News

BREAKING: Shooting reported near Prien Lake Mall

McNeese Sports

Cowgirls set for a noisy start

life

Listen up: Colossus chime newest feature at Millennium Park

McNeese Sports

Cowboys open against tough foe

Jim Beam

Jim Beam column: Don’t wait up to see who won

life

Gators are back: Refurbished Alligator Cypress Pond reopens to visitors

Local News

BREAKING: Helicopter crash kills 3 in Iowa

high-school Sports

Field of dreams: Lacassine High to soon have home field advantage